A Raleigh-based company developing treatments for Alzheimer’s and dementia has raised slightly more than $2 million in a private equity offering, according to a filing Friday with the Securities and Exchange Commission.

Muses Labs Inc. raised the money from 21 investors, according to the filing, and is seeking to raise an additional $3.7 million.

Muses Labs believes tailored treatment can help patients find a road back to cognitive fitness.

The company has developed the MEND — metabolic enhancement for neuro-degeneration — protocol, which is used in partnership with mental health care providers at Carolina Partners throughout its 27 locations in the state.

The Raleigh-based company was co-founded by chief executive officer Vik Chandra and chief technology officer John Q. Walker.

Chandra has more than 26 years of technology leadership and development experience, including two decades with IBM.

Walker is a computer software veteran and serial entrepreneur with nearly four decades at IBM and three start-ups under his belt. He led the team in the development of the groundbreaking algorithms while managing data in a high-security, HIPAA-compliant environment.

Companies relying on a Reg D exemption do not have to register their offering of securities with the SEC, but they must file what’s known as a Form D electronically with the SEC after they first sell their securities.